REFERENCES

• CresonTK.YuanP.ManjiHK.ChenG.Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate.J Mol Neurosci.20093712313418677583
   PubMed Web of Science ®Google Scholar
• EinatH.YuanP.GouldTD.et al.The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.J Neurosci.2003237311731612917364
   PubMed Web of Science ®Google Scholar
• HaoY.CresonT.ZhangL.et al.Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.J Neurosci.2004246590659915269271
   PubMed Web of Science ®Google Scholar
• HuangX.WuDY.ChenG.ManjiH.ChenDF.Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2dependent mechanism.Invest Ophthalmol Vis Sci.20034434735412506095
   PubMed Web of Science ®Google Scholar
• SweattJD.Mitogen-activated protein kinases in synaptic plasticity and memory.Curr Opin Neurobiol.20041431131715194111
   PubMed Web of Science ®Google Scholar
• ChenG.CresonT.SharonE.HaoY.WangG.Neurotrophic actions of mood-stabilizers: a recent research discovery and its potential clinical applications.Curr Psych Rev.20051173185
   Google Scholar
• ChenG.ManjiHK.The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.Curr Opin Psychiatry.20061931332316612219
   PubMed Web of Science ®Google Scholar
• RiccioA.AhnS.DavenportCM.BlendyJA.GintyDD.Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons.Science.19992862358236110600750
   PubMed Web of Science ®Google Scholar
• TaoX.FinkbeinerS.ArnoldDB.ShaywitzAJ.GreenbergME.Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism.Neuron.1998207097269581763
   PubMed Web of Science ®Google Scholar
• YuanPX.HuangLD.JiangYM.GutkindJS.ManjiHK.ChenG.The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth.J Biol Chem.2001276316743168311418608
   PubMed Web of Science ®Google Scholar
• Di DanielE.MudgeAW.MaycoxPR.Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.Bipolar Disord.20057334115654930
   PubMed Web of Science ®Google Scholar
• JungGA.YoonJY.MoonBS.et al.Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the betacatenin-Ras-ERK-p21Cip/WAF1 pathway.BMC Cell Biol.200896619068119
   PubMedGoogle Scholar
• HsiehJ.NakashimaK.KuwabaraT.MejiaE.GageFH.Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells.Proc Natl Acad Sci U S A.2004101166591666415537713
   PubMed Web of Science ®Google Scholar
• MichaelisM.SuhanT.MichaelisUR.et al.Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells.Cell Death Differ.20061344645316167071
   PubMed Web of Science ®Google Scholar
• MaiL.JopeRS.LiX.BDNF-mediated signal transduction is modulated by GSObeta and mood stabilizing agents.J Neurochem.200282758312091467
   PubMed Web of Science ®Google Scholar
• KopniskyKL.Chalecka-FranaszekE.Gonzalez-ZuluetaM.ChuangDM.Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities.Neuroscience.200311642543512559097
   PubMed Web of Science ®Google Scholar
• PardoR.AndreolottiAG.RamosB.PicatosteF.ClaroE.Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms.J Neurochem.20038741742614511119
   PubMed Web of Science ®Google Scholar
• SonH.YuIT.HwangSJ.et al.Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus.J Neurochem.20038587288112716419
   PubMed Web of Science ®Google Scholar
• KimJS.ChangMY.YuIT.et al.Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo.J Neurochem.20048932433615056276
   PubMed Web of Science ®Google Scholar
• MajR.FarielloRG.UkmarG.et al.PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat.Eur J Pharmacol.199835927329831289
   PubMed Web of Science ®Google Scholar
• WiardRP.DickersonMC.BeekO.NortonR.CooperBR.Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia.Stroke.1995264664727886726
   PubMed Web of Science ®Google Scholar
• YoungC.StraikoMM.JohnsonSA.CreeleyC.OlneyJW.Ethanol causes and lithium prevents neuroapoptosis and suppression of pERK in the infant mouse brain.Neurobiol Dis.20083135536018595723
   PubMed Web of Science ®Google Scholar
• SinnDI.KimSJ.ChuK.et al.Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.Neurobiol Dis.20072646447217398106
   PubMed Web of Science ®Google Scholar
• CasuMA.SannaA.SpadaGP.FalzoiM.MongeauR.PaniL.Effects of acute and chronic valproate treatments on p-CREB levels in the rat amygdala and nucleus accumbens.Brain Res.20071141152417270156
   PubMed Web of Science ®Google Scholar
• CantleyLC.The phosphoinositide 3-kinase pathway.Science.20022961655165712040186
   PubMed Web of Science ®Google Scholar
• HuangEJ.ReichardtLF.Trk receptors: roles in neuronal signal transduction.Annu Rev Biochem.20037260964212676795
   PubMed Web of Science ®Google Scholar
• SegalRA.Selectivity in neurotrophin signaling: theme and variations.Annu Rev Neurosci.20032629933012598680
   PubMed Web of Science ®Google Scholar
• CrossDA.AlessiDR.CohenP.AndjelkovichM.HemmingsBA.Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.Nature.19953787857898524413
   PubMed Web of Science ®Google Scholar
• Chalecka-FranaszekE.ChuangDM.Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.Proc Natl Acad Sci U S A.1999968745875010411946
   PubMed Web of Science ®Google Scholar
• De SarnoP.LiX.JopeRS.Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.Neuropharmacology.2002431158116412504922
   PubMed Web of Science ®Google Scholar
• KozlovskyN.AmarS.BelmakerRH.AgamG.Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex.Int J Neuropsychopharrnacol.20069337342
   PubMed Web of Science ®Google Scholar
• YazlovitskayaEM.EdwardsE.ThotalaD.et al.Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation.Cancer Res.200666111791118617145862
   PubMed Web of Science ®Google Scholar
• BeaulieuJM.SotnikovaTD.YaoWD.et al.Lithium antagonizes dopamlne-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.Proc Natl Acad Sci U S A.20041015099510415044694
   PubMed Web of Science ®Google Scholar
• GurpurPB.LiuJ.BurkinDJ.KaufmanSJ.Valproic acid activates the PBK/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy.Am J Pathol.2009174999100819179609
   PubMed Web of Science ®Google Scholar
• FukumotoT.MorinobuS.OkamotoY.KagayaA.YamawakiS.Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain.Psychopharmacoiogy (Berl).2001158100106
   PubMed Web of Science ®Google Scholar
• AngelucciF.AloeL.Jimenez-VasquezP.MatheAA.Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression.Int J Neuropsychopharrnacol.20036225231
   PubMed Web of Science ®Google Scholar
• JacobsenJP.MorkA.The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels.Brain Res.2004102418319215451381
   PubMed Web of Science ®Google Scholar
• CastroLM.GallantM.NilesLP.Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.J Neurochem.2005951227123616313512
   PubMed Web of Science ®Google Scholar
• FreyBN.AndreazzaAC.CereserKM.et al.Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania.Life Sci.20067928128616460767
   PubMed Web of Science ®Google Scholar
• ChenPS.PengGS.LiG.et al.Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.Mol Psychiatry.2006111116112516969367
   PubMed Web of Science ®Google Scholar
• WalzJC.FreyBN.AndreazzaAC.et al.Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania.J Psychiatr Res.20084241642117512948
   PubMed Web of Science ®Google Scholar
• BredyTW.WuH.CregoC.ZellhoeferJ.SunYE.BaradM.Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear.Learn Mem.20071426827617522015
   PubMed Web of Science ®Google Scholar
• YasudaS.LiangMH.MarinovaZ.YahyaviA.ChuangDM.The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.Mol Psychiatry.200914515917925795
   PubMed Web of Science ®Google Scholar
• OmataN.MurataT.TakamatsuS.et al.Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treatment.Bipolar Disord.20081036036818402624
   PubMed Web of Science ®Google Scholar
• WuX.ChenPS.DallasS.et al.Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons.Int J Neuropsychopharrnacol.20081111231134
   PubMed Web of Science ®Google Scholar
• GuoS.AraiK.StinsMF.ChuangDM.LoEH.Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes.Stroke.20094065265518974377
   PubMed Web of Science ®Google Scholar
• LeyheT.EschweilerGW.StranskyE.et al.Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.J Alzheirners Dis.200916649656
   PubMed Web of Science ®Google Scholar
• WlodarczykBC.CraigJC.BennettGD.CalvinJA.FinnellRH.Valproic acid-induced changes in gene expression during neurulation in a mouse model.Teratology.1996542842979098922
   PubMedGoogle Scholar
• ChenG.ZengWZ.YuanPX.et al.The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS.J Neurochem.1999728798829930766
   PubMed Web of Science ®Google Scholar
• GhribiO.HermanMM.SpauldingNK.SavoryJ.Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation.J Neurochem.20028213714512091474
   PubMed Web of Science ®Google Scholar
• CuiSS.YangCP.BowenRC.et al.Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats.Brain Res.2003975(1-2)22923612763612
   PubMed Web of Science ®Google Scholar
• ZhouR.GrayNA.YuanP.et al.The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers.J Neurosci.2005254493450215872096
   PubMed Web of Science ®Google Scholar
• YickLW.SoKF.CheungPT.WuWT.Lithium chloride reinforces the regeneration-promoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury.J Neurotrauma.20042193294315307905
   PubMed Web of Science ®Google Scholar
• KagaS.ZhanL.AltafE.MaulikN.Glycogen synthase kinase-3beta/betacatenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.J Mol Cell Cardiol.20064013814716288908
   PubMed Web of Science ®Google Scholar
• ChenG.RajkowskaG.DuF.Seraji-BozorgzadN.ManjiHK.Enhancement of hippocampal neurogenesis by lithium.J Neurochem.2000751729173410987856
   PubMed Web of Science ®Google Scholar
• YanXB.HouHL.WuLM.LiuJ.ZhouJN.Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia.Neuropharmacology.20075348749517686496
   PubMed Web of Science ®Google Scholar
• YuIT.ParkJY.KimSH.LeeJS.KimYS.SonH.Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation.Neuropharmacology.20095647348019007798
   PubMed Web of Science ®Google Scholar
• WuF.XingD.PengZ.RaoT.Enhanced rat sciatic nerve regeneration through silicon tubes implanted with valproic acid.J Reconstr Microsurg.20082426727618496777
   PubMed Web of Science ®Google Scholar
• SchuettaufF.RejdakR.ThalerS.et al.Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat.Exp Eye Res.2006831128113416876158
   PubMed Web of Science ®Google Scholar
• DillJ.WangH.ZhouF.LiS.Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS.J Neurosci.2008288914892818768685
   PubMed Web of Science ®Google Scholar
• WoodGE.YoungLT.ReaganLP.ChenB.McEwenBS.Stress-induced structural remodeling in hippocampus: prevention by lithium treatment.Proc Natl Acad Sci U S A.20041013973397815001711
   PubMed Web of Science ®Google Scholar
• HeimC.NemeroffCB.The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.Biol Psychiatry.2001491023103911430844
   PubMed Web of Science ®Google Scholar
• McEwenBS.Mood disorders and allostatic load.Biol Psychiatry.2003542002712893096
   PubMed Web of Science ®Google Scholar
• ShelineYl.Neuroimaging studies of mood disorder effects on the brain.Biol Psychiatry.20035433835212893109
   PubMed Web of Science ®Google Scholar
• BownCD.WangJF.YoungLT.Attenuation of N-methyl-D-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers.Neuroscience.200311794995512654346
   PubMed Web of Science ®Google Scholar
• McDonaldC.ZanelliJ.Rabe-HeskethS.et al.Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder.Biol Psychiatry.2004 Sep 155641141715364039
   PubMed Web of Science ®Google Scholar
• KemptonMJ.GeddesJR.EttingerU.WilliamsSC.GrasbyPM.Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder.Arch Gen Psychiatry.2008651017103218762588
   PubMed Web of Science ®Google Scholar
• DrevetsWC.PriceJL.SimpsonJR.Jr.et al.Subgenual prefrontal cortex abnormalities in mood disorders.Nature.19973868248279126739
   PubMed Web of Science ®Google Scholar
• HirayasuY.ShentonME.SalisburyDF.et al.Subgenual cingulate cortex volume in first-episode psychosis.Am J Psychiatry.19991561091109310401458
   PubMed Web of Science ®Google Scholar
• SassiRB.BrambillaP.HatchJP.et al.Reduced left anterior cingulate volumes in untreated bipolar patients.Biol Psychiatry.20045646747515450781
   PubMed Web of Science ®Google Scholar
• CampbellS.MarriottM.NahmiasC.MacQueenGM.Lower hippocampal volume in patients suffering from depression: a meta-analysis.Am J Psychiatry.200416159860715056502
   PubMed Web of Science ®Google Scholar
• AtmacaM.YildirimH.OzdemirH.OgurE.TezcanE.Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine.Psychol Med.20073712112917094813
   PubMed Web of Science ®Google Scholar
• BertolinoA.FryeM.CallicottJH.et al.Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.Biol Psychiatry.20035390691312742678
   PubMed Web of Science ®Google Scholar
• WinsbergME.SachsN.TateDL.AdalsteinssonE.SpielmanD.KetterTA.Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder.Biol Psychiatry.20004747548110715353
   PubMed Web of Science ®Google Scholar
• SoaresJC.Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder.Int J Neuropsychopharrnacol.20036171180
   PubMed Web of Science ®Google Scholar
• CecilKM.DelBelloMP.SellarsMC.StrakowskiSM.Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.J Child Adolesc Psychopharmacol.20031354555514977467
   PubMed Web of Science ®Google Scholar
• Yildiz-YesilogluA.AnkerstDP.Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.Prog Neuropsychopharrnacol Biol Psychiatry.200630969995
   PubMed Web of Science ®Google Scholar
• OlveraRL.CaetanoSC.FonsecaM.et al.Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients.J Child Adolesc Psychopharmacol.20071746147317822341
   PubMed Web of Science ®Google Scholar
• MooreGJ.BebchukJM.WildsIB.ChenG.ManjiHK.MenjiHK.Lithium-induced increase in human brain grey matter.Lancet.20003561241124211072948
   PubMed Web of Science ®Google Scholar
• SassiRB.NicolettiM.BrambillaP.et al.Increased gray matter volume in lithium-treated bipolar disorder patients.Neurosci Lett.200232924324512165422
   PubMed Web of Science ®Google Scholar
• BeardenCE.ThompsonPM.DalwaniM.et al.Greater cortical gray matter density in lithium-treated patients with bipolar disorder.Biol Psychiatry.20076271617240360
   PubMed Web of Science ®Google Scholar
• BeyerJL.BurchittB.GersingK.KrishnanKR.Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder.Psychopharmacol Bull.20084110211418362874
   PubMedGoogle Scholar
• BeardenCE.ThompsonPM.DuttonRA.et al.Three-dimensional mapping of hippocampal anatomy in unmedlcated and lithium-treated patients with bipolar disorder.Neuropsychopharmacology.2008331229123817687266
   PubMed Web of Science ®Google Scholar
• YucelK.McKinnonMC.TaylorVH.et al.Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study.Psychopharmacology (Berl).200719535736717705060
   PubMed Web of Science ®Google Scholar
• YucelK.TaylorVH.McKinnonMC.et al.Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment.Neuropsychopharmacology.20083336136717406649
   PubMed Web of Science ®Google Scholar
• FolandLC.AltshulerLL.SugarCA.et al.Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium.Neuroreport.20081922122418185112
   PubMed Web of Science ®Google Scholar
• AtmacaM.OzdemirH.CetinkayaS.et al.Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine.J Psychiatr Res.20074182182716950400
   PubMed Web of Science ®Google Scholar
• SilverstonePH.WuRH.O'DonnellT.UlrichM.AsgharSJ.HanstockCC.Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.Int Clin Psychopharmacol.200318737912598817
   PubMed Web of Science ®Google Scholar
• BrambillaP.StanleyJA.NicolettiMA.et al.1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients.J Affect Disord.200586616715820271
   PubMed Web of Science ®Google Scholar
• BrambillaP.StanleyJA.SassiRB.et al.1H MRS Study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration.Neuropsychopharmacology.2004291918192415257303
   PubMed Web of Science ®Google Scholar
• ForesterBP.FinnCT.BerlowYA.WardropM.RenshawPF.MooreCM.Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.Bipolar Disord.20081069170018837863
   PubMed Web of Science ®Google Scholar
• ChuangDM.Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?Crit Rev Neurobiol.200416839015581403
   PubMedGoogle Scholar
• ChuangDM.ManjiHK.In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?Biol Psychiatry.2007624617572175
   PubMed Web of Science ®Google Scholar
• NonakaS.ChuangDM.Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.Neuroreport.19989208120849674597
   PubMed Web of Science ®Google Scholar
• RenM.SenatorovW.ChenRW.ChuangDM.Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model.Proc Natl Acad Sci U S A.20031006210621512732732
   PubMed Web of Science ®Google Scholar
• XuJ.CulmanJ.BlumeA.BrechtS.GohlkeP.Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.Stroke.2003341287129212677021
   PubMed Web of Science ®Google Scholar
• XuXH.HuaYN.ZhangHL.et al.Greater stress protein expression enhanced by combined prostaglandin A1 and lithium in a rat model of focal ischemia.Acta Pharmacol Sin.2007281097110417640469
   PubMed Web of Science ®Google Scholar
• XuXH.ZhangHL.HanR.GuZL.QinZH.Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia.Brain Res.2006110215416216797496
   PubMed Web of Science ®Google Scholar
• MaJ.ZhangGY.LiuY.YanJZ.HaoZB.Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia.Neurosci Res.20044935736215236860
   PubMed Web of Science ®Google Scholar
• MaJ.ZhangGY.Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia.Neurosci Lett.200334818518912932824
   PubMed Web of Science ®Google Scholar
• SasakiT.HanF.ShiodaN.MoriguchiS.et al.Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model.Brain Res.200611089810616843447
   PubMed Web of Science ®Google Scholar
• YanXB.WangSS.HouHL.JiR.ZhouJN.Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia.Behav Brain Res.200717728228917210190
   PubMed Web of Science ®Google Scholar
• HanR.GaoB.ShengR.et al.Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia.Acta Pharmacol Sin.2008291141114918817617
   PubMed Web of Science ®Google Scholar
• MastroiacovoF.BuscetiCL.BiagioniF.et al.Induction of the Wnt antagonist, Dickkopf-1, contributes to the development of neuronal death in models of brain focal ischemia.J Cereb Blood Flow Metab.20092926427618827832
   PubMed Web of Science ®Google Scholar
• RenM.LengY.JeongM.LeedsPR.ChuangDM.Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.J Neurochem.2004891358136715189338
   PubMed Web of Science ®Google Scholar
• KimHJ.RoweM.RenM.HongJS.ChenPS.ChuangDM.Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.J Pharmacol Exp Ther.200732189290117371805
   PubMed Web of Science ®Google Scholar
• ZarateCA.QuirozJ.PayneJ.ManjiHK.Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders.Psychopharmacol Bull.200236358312858143
   PubMedGoogle Scholar
• SugaiF.YamamotoY.MiyaguchiK.et al.Benefit of valproic acid in suppressing disease progression of ALS model mice.Eur J Neurosci.2004203179318315579172
   PubMed Web of Science ®Google Scholar
• FornaiF.LongoneP.CafaroL.et al.Lithium delays progression of amyotrophic lateral sclerosis.Proc Natl Acad Sci U S A.20081052052205718250315
   PubMed Web of Science ®Google Scholar
• FengHL.LengY.MaCH.ZhangJ.RenM.ChuangDM.Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.Neuroscience.200815556757218640245
   PubMed Web of Science ®Google Scholar
• PhielCJ.WilsonCA.LeeVM.KleinPS.GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.Nature.200342343543912761548
   PubMed Web of Science ®Google Scholar
• RockensteinE.TorranceM.AdameA.et al.Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.J Neurosci.2007271981199117314294
   PubMed Web of Science ®Google Scholar
• De FerrariGV.ChaconMA.BarriaMl.et al.Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by betaamyloid fibrils.Mol Psychiatry.2003819520812610652
   PubMed Web of Science ®Google Scholar
• QingH.HeG.LyPT.et al.Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models.J Exp Med.20082052781278918955571
   PubMed Web of Science ®Google Scholar
• CaccamoA.OddoS.TranLX.LaFerlaFM.Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.Am J Pathol.20071701669167517456772
   PubMed Web of Science ®Google Scholar
• AngstJ.GammaA.Gerber-WerderR.ZarateCA.Jr.ManjiHK.Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients?Int J Psychiatry Clin Practice.20071128
   PubMed Web of Science ®Google Scholar
• KessingLV.SondergardL.FormanJL.AndersenPK.Lithium treatment and risk of dementia.Arch Gen Psychiatry.2008651331133518981345
   PubMed Web of Science ®Google Scholar
• NunesPV.ForlenzaOV.GattazWF.Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder.Br J Psychiatry.200719035936017401045
   PubMed Web of Science ®Google Scholar
• WataseK.GatchelJR.SunY.et al.Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.PLoS Med.20074e18217535104
   PubMed Web of Science ®Google Scholar
• WeiH.QinZH.SenatorovVV.et al.Lithium suppresses excitotoxicityinduced striatal lesions in a rat model of Huntington's disease.Neuroscience.200110660361211591460
   PubMed Web of Science ®Google Scholar
• SenatorovVV.RenM.KanaiH.WeiH.ChuangDM.Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.Mol Psychiatry.2004937138514702090
   PubMed Web of Science ®Google Scholar
• YoudimMB.ArrafZ.Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.Neuropharmacology.2004461130114015111020
   PubMed Web of Science ®Google Scholar
• EverallIP.BellC.MalloryM.et al.Lithium ameliorates HIV-gp120-mediated neurotoxicity.Mol Cell Neurosci.20022149350112498789
   PubMed Web of Science ®Google Scholar
• DouH.BirusinghK.FaraciJ.et al.Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis.J Neurosci.2003239162917014534250
   PubMed Web of Science ®Google Scholar
• D'SaC.DumanRS.Antidepressants and neuroplasticity.Bipolar Disord.2002418319412180273
   PubMed Web of Science ®Google Scholar
• NibuyaM.MorinobuS.DumanRS.Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.J Neurosci.199515753975477472505
   PubMed Web of Science ®Google Scholar
• NibuyaM.NestlerEJ.DumanRS.Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.J Neurosci.199616236523728601816
   PubMed Web of Science ®Google Scholar
• HunsbergerJG.NewtonSS.BennettAH.et al.Antidepressant actions of the exercise-regulated gene VGF.Nat Med.2007131476148218059283
   PubMed Web of Science ®Google Scholar
• BerchtoldNC.KesslakJP.CotmanCW.Hippocampal brain-derived neurotrophic factor gene regulation by exercise and the medial septum.J Neurosci Res.20026851152112111841
   PubMed Web of Science ®Google Scholar
• FarmerJ.ZhaoX.van PraagH.WodtkeK.GageFH.ChristieBR.Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo.Neuroscience.2004124717914960340
   PubMed Web of Science ®Google Scholar
• NeeperSA.Gomez-PinillaF.ChoiJ.CotmanCW.Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain.Brain Res.199672649568836544
   PubMed Web of Science ®Google Scholar
• VaynmanS.YingZ.Gomez-PinillaF.Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition.Eur J Neurosci.2004202580259015548201
   PubMed Web of Science ®Google Scholar
• YingZ.RoyRR.EdgertonVR.Gomez-PinillaF.Exercise restores levels of neurotrophins and synaptic plasticity following spinal cord injury.Exp Neurol.200519341141915869943
   PubMed Web of Science ®Google Scholar
• ChenMJ.Russo-NeustadtAA.Running exercise-induced up-regulation of hippocampal brain-derived neurotrophic factor is CREB-dependent.Hippocampus.2009. In press
   Web of Science ®Google Scholar
• ShimizuE.HashimotoK.OkamuraN.et al.Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.Biol Psychiatry.200354707512842310
   PubMed Web of Science ®Google Scholar
• SiuciakJA.LewisDR.WiegandSJ.LindsayRM.Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).Pharmacol Biochem Behav.1997561311378981620
   PubMed Web of Science ®Google Scholar
• ShirayamaY.ChenAC.NakagawaS.RussellDS.DumanRS.Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.J Neurosci.2002223251326111943826
   PubMed Web of Science ®Google Scholar
• AzmitiaEC.MurphyRB.Whitaker-AzmitiaPM.MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.Brain Res.1990510971031969761
   PubMed Web of Science ®Google Scholar
• PanHS.WangRY.MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system.Brain Res.19915393323361675911
   PubMed Web of Science ®Google Scholar
• MercierG.LennonAM.RenoufB.et al.MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes.J Mol Neurosci.20042420721615456934
   PubMed Web of Science ®Google Scholar
• HeikkilaRE.ManzinoL.CabbatFS.DuvoisinRC.Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.Nature.19843114674696332989
   PubMed Web of Science ®Google Scholar
• WeinrebO.AmitT.Bar-AmO.Yogev-FalachM.YoudimMB.The neuroprotective mechanism of action of the multimodal drug ladostigil.Front Biosci.2008135131513718508575
   PubMed Web of Science ®Google Scholar
• Yogev-FalachM.AmitT.Bar-AmO.WeinstockM.YoudimMB.Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline.FASEB J.2002161674167612206996
   PubMed Web of Science ®Google Scholar
• CarroE.TrejoJL.BusiguinaS.Torres-AlemanI.Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy.J Neurosci.2001215678568411466439
   PubMed Web of Science ®Google Scholar
• MalbergJE.EischAJ.NestlerEJ.DumanRS.Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.J Neurosci.2000209104911011124987
   PubMed Web of Science ®Google Scholar
• HitoshiS.MarutaN.HigashiM.KumarA.KatoN.IkenakaK.Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress.J Neurosci Res.2007853574358517668856
   PubMed Web of Science ®Google Scholar
• CzehB.MichaelisT.WatanabeT.et al.Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine.Proc Natl Acad Sci U S A.200198127961280111675510
   PubMed Web of Science ®Google Scholar
• MadsenTM.TreschowA.BengzonJ.BolwigTG.LindvallO.TingstrornA.Increased neurogenesis in a model of electroconvulsive therapy.Biol Psychiatry.2000471043104910862803
   PubMed Web of Science ®Google Scholar
• ChenF.MadsenTM.WegenerG.NyengaardJR.Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus.Eur Neuropsychopharrnacol.200919329338
   PubMed Web of Science ®Google Scholar
• PereraTD.CoplanJD.LisanbySH.et al.Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates.J Neurosci.2007274894490117475797
   PubMed Web of Science ®Google Scholar
• van PraagH.ChristieBR.SejnowskiTJ.GageFH.Running enhances neurogenesis, learning, and long-term potentiation in mice.Proc Natl Acad Sci U S A.199996134271343110557337
   PubMed Web of Science ®Google Scholar
• MaoY.GeX.FrankCL.MadisonJM.et al.Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling.Cell.20091361017103119303846
   PubMed Web of Science ®Google Scholar
• KatoM.SerrettiA.Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.Mol Psychiatry. In press
   Google Scholar
• EganMF.KojimaM.CallicottJH.et al.The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.Cell.200311225726912553913
   PubMed Web of Science ®Google Scholar
• ChenZY.JingD.BathKG.et al.Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior.Science.200631414014317023662
   PubMed Web of Science ®Google Scholar
• CarrollCurtisGC.MendelsJ.Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.Arch Gen Psychiatry.19763310391044962488
   PubMed Web of Science ®Google Scholar
• CarrollBJ.CurtisGC.MendelsJ.Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.Arch Gen Psychiatry.19763310511058962489
   PubMed Web of Science ®Google Scholar
• ShelineYl.SanghaviM.MintunMA.GadoMH.Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression.J Neurosci.1999195034504310366636
   PubMed Web of Science ®Google Scholar
• ShelineYl.WangPW.GadoMH.CsernanskyJG.VannierMW.Hippocampal atrophy in recurrent major depression.Proc Natl Acad Sci U S A.199693390839138632988
   PubMed Web of Science ®Google Scholar
• BremnerJD.ScottTM.DelaneyRC.et al.Deficits in short-term memory in posttraumatic stress disorder.Am J Psychiatry.1993150101510198317569
   PubMed Web of Science ®Google Scholar
• BremnerJD.RandallP.ScottTM.et al.MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder.Am J Psychiatry.19951529739817793467
   PubMed Web of Science ®Google Scholar
• BuellerJA.AftabM.SenS.Gomez-HassanD.BurmeisterM.ZubietaJK.BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects.Biol Psychiatry.20065981281516442082
   PubMed Web of Science ®Google Scholar
• MalbergJE.DumanRS.Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment.Neuropsychopharmacology.2003281562157112838272
   PubMed Web of Science ®Google Scholar
• YukimasaT.YoshimuraR.TamagawaA.et al.High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.Pharmacopsychiatry.200639525916555165
   PubMed Web of Science ®Google Scholar
• ZanardiniR.GazzoliA.VentrigliaM.et al.Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.J Affect Disord.200691838616448701
   PubMed Web of Science ®Google Scholar
• NasrallahHA.Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.Mol Psychiatry.200813273517848919
   PubMed Web of Science ®Google Scholar
• KapurS.ArenovichT.AgidO.ZipurskyR.LindborgS.JonesB.Evidence for onset of antipsychotic effects within the first 24 hours of treatment.Am J Psychiatry.200516293994615863796
   PubMed Web of Science ®Google Scholar
• AgidO.KapurS.ArenovichT.ZipurskyRB.Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected.Arch Gen Psychiatry.2003601228123514662555
   PubMed Web of Science ®Google Scholar
• CaseyDE.Tardive dyskinesia and atypical antipsychotic drugs.Schizophr Res.199935 (suppl)S61S6610190226
   PubMed Web of Science ®Google Scholar
• JonesPB.BarnesTR.DaviesL.et al.Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).Arch Gen Psychiatry.2006631079108717015810
   PubMed Web of Science ®Google Scholar
• EderU.MangwethB.EbenbichlerC.et al.Association of olanzapineinduced weight gain with an increase in body fat.Am J Psychiatry.20011581719172211579009
   PubMed Web of Science ®Google Scholar
• FumagalliF.FrascaA.SpartaM.DragoF.RacagniG.RivaMA.Longterm exposure to the atypical antipsychotic olanzapine differently up-regulates extracellular signal-regulated kinases 1 and 2 phosphorylation in subcellular compartments of rat prefrontal cortex.Mol Pharmacol.2006691366137216391238
   PubMed Web of Science ®Google Scholar
• BrowningJL.PatelT.BrandtPC.YoungKA.HolcombLA.HicksPB.Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions.Biol Psychiatry.20055761762315780848
   PubMed Web of Science ®Google Scholar
• LuXH.BradleyRJ.DwyerDS.Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogenactivated protein kinase p38.Brain Res.20041011586815140644
   PubMed Web of Science ®Google Scholar
• LuXH.DwyerDS.Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways.J Mol Neurosci.200527436416055946
   PubMed Web of Science ®Google Scholar
• BaiO.ZhangH.LiXM.Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus.Brain Res.20041010818615126120
   PubMed Web of Science ®Google Scholar
• EnglJ.LaimerM.NiederwangerA.et al.Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells.Mol Psychiatry.2005101089109616130009
   PubMed Web of Science ®Google Scholar
• PozziL.HakanssonK.UsielloA.et al.Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum.J Neurochem.20038645145912871586
   PubMed Web of Science ®Google Scholar
• LipskaBK.KhaingZZ.WeickertCS.WeinbergerDR.BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs.Eur J Neurosci.20011413514411488957
   PubMed Web of Science ®Google Scholar
• Chlan-FourneyJ.AsheP.NylenK.JuorioAV.LiXM.Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration.Brain Res.2002954112012393228
   PubMed Web of Science ®Google Scholar
• BaiO.Chlan-FourneyJ.BowenR.KeeganD.LiXM.Expression of brainderived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs.J Neurosci Res.20037112713112478621
   PubMed Web of Science ®Google Scholar
• PillaiA.TerryAV.Jr.MahadikSP.Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus.Schizophr Res.2006829510616442781
   PubMed Web of Science ®Google Scholar
• DeanCE.Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?Prog Neuropsychopharrnacol Biol Psychiatry.200630174189
   PubMed Web of Science ®Google Scholar
• ParikhV.KhanMM.MahadikSP.Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol.Neurosci Lett.200435613513914746882
   PubMed Web of Science ®Google Scholar
• MitchellIJ.CooperAC.GriffithsMR.CooperAJ.Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat.Neuroscience.2002109899911784702
   PubMed Web of Science ®Google Scholar
• NavariS.DazzanP.Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.Psychol Med. In press
   Google Scholar
• Dorph-PetersenKA.PierriJN.PerelJM.SunZ.SampsonAR.LewisDA.The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.Neuropsychopharmacology.2005301649166115756305
   PubMed Web of Science ®Google Scholar
• ChakosMH.ShirakawaO.LiebermanJ.LeeH.BilderR.TammingaCA.Striatal enlargement in rats chronically treated with neuroleptic.Biol Psychiatry.1998446756849798070
   PubMed Web of Science ®Google Scholar
• BaiO.WeiZ.LuW.BowenR.KeeganD.LiXM.Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal.J Neurosci Res.2002692788312111809
   PubMed Web of Science ®Google Scholar
• QingH.XuH.WeiZ.GibsonK.LiXM.The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis.Eur J Neurosci.2003171563157012752374
   PubMed Web of Science ®Google Scholar
• YulugB.YildizA.HudaogluO.KilicE.CamE.SchabitzWR.Olanzapine attenuates brain damage after focal cerebral ischemia in vivo.Brain Research Bulletin.20067129630017113959
   PubMed Web of Science ®Google Scholar
• BianQ.KatoT.MonjiA.et al.The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma.Prog Neuropsychopharrnacol Biol Psychiatry.2007324248
   PubMed Web of Science ®Google Scholar
• YulugB.YildizA.GuzelO.KilicE.SchabitzWR.KilicE.Risperidone attenuates brain damage after focal cerebral ischemia in vivo.Brain Research Bulletin.20066965665916716834
   PubMed Web of Science ®Google Scholar
• XuH.QingH.LuRB.et al.Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus.Neurosci Lett.2002321656811872258
   PubMed Web of Science ®Google Scholar
• DawirsRR.HildebrandtK.Teuchert-NoodtG.Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus.J Neural Transm.19981053173279660110
   PubMed Web of Science ®Google Scholar
• HalimND.WeickertCS.McClintockBW.WeinbergerDR.LipskaBK.Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology. 20042910631069
   Google Scholar
• WangHD.DunnavantFD.JarmanT.DeutchAY.Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat.Neuropsychopharmacology.2004291230123815085089
   PubMed Web of Science ®Google Scholar
• KippinTE.KapurS.van der KooyD.Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs.J Neurosci.20052558152315958748
   PubMed Web of Science ®Google Scholar
• LuoC.XuH.LiXM.Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress.Brain Res.20051063323916271709
   PubMed Web of Science ®Google Scholar
• HeimbergC.KomoroskiRA.LawsonWB.CardwellD.KarsonCN.Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.Psychiatry Res.1998831051159818736
   PubMed Web of Science ®Google Scholar
• BrausDF.EndeG.Weber-FahrW.DemirakcaT.TostH.HennFA.Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia.Eur Neuropsychopharrnacol.200212145152
   PubMed Web of Science ®Google Scholar
• BertolinoA.CailicottJH.MattayVS.et al.The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia.Biol Psychiatry.200149394611163778
   PubMed Web of Science ®Google Scholar
• LawrieSM.AbukmeilSS.Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies.Br J Psychiatry.19981721101209519062
   PubMed Web of Science ®Google Scholar
• LiebermanJA.Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective.Biol Psychiatry.19994672973910494440
   PubMed Web of Science ®Google Scholar
• LiebermanJA.TollefsonGD.CharlesC.et al.Antipsychotic drug effects on brain morphology in first-episode psychosis.Arch Gen Psychiatry.20056236137015809403
   PubMed Web of Science ®Google Scholar
• DelBelloMP.CecilKM.AdlerCM.DanielsJP.StrakowskiSM.Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.Neuropsychopharmacology.2006311264127316292323
   PubMed Web of Science ®Google Scholar